close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

UroGen Pharma Ltd. - Ordinary Shares (NQ:URGN)

18.71 -1.10 (-5.55%)
Streaming Delayed Price Updated: 11:06 AM EST, Nov 5, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about UroGen Pharma Ltd. - Ordinary Shares

< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
Earnings Scheduled For May 10, 2022
Companies Reporting Before The Bell • The Middleby (NASDAQ:MIDD) is expected to report quarterly earnings at $2.10 per share on revenue of $935.99 million. 
Via Benzinga
Recap: UroGen Pharma Q4 Earnings
UroGen Pharma (NASDAQ:URGN) reported its Q4 earnings results on Monday, March 21, 2022 at 08:00 AM. Here's what investors need to know about the announcement. Earnings... 
Via Benzinga
Earnings Outlook For UroGen Pharma
UroGen Pharma (NASDAQ:URGN) is set to give its latest quarterly earnings report on Tuesday, 2022-05-10. Here's what investors need to know before the announcement. Analysts estimate that UroGen Pharma... 
Via Benzinga
UroGen Pharma to Report First Quarter 2022 Financial Results on Tuesday, May 10, 2022
From UroGen Pharma Ltd.
Via Business Wire
UroGen Announces FDA Clearance of IND Application for the Investigational Immunotherapy UGN-301 (zalifrelimab) Intravesical Solution in Recurrent Non-Muscle Invasive Bladder Cancer
From UroGen Pharma Ltd.
Via Business Wire
UroGen Pharma's Return On Capital Employed Overview
According to data from Benzinga Pro, during Q4, UroGen Pharma's (NASDAQ:URGN) reported sales totaled $16.17 million. Despite a 5.82% increase in earnings, the company posted a... 
Via Benzinga
UroGen Pharma Earnings Preview
UroGen Pharma (NASDAQ:URGN) is set to give its latest quarterly earnings report on Monday, 2022-03-21. Here's what investors need to know before the announcement. Analysts... 
Via Benzinga
Earnings Scheduled For March 10, 2022
Companies Reporting Before The Bell • Despegar.com (NYSE:DESP) is expected to report quarterly loss at $0.08 per share on revenue of $110.93 million. • ProShares... 
Via Benzinga
UroGen Pharma Reports Fourth Quarter and Full-year 2021 Financial Results and Recent Corporate Developments
From UroGen Pharma Ltd.
Via Business Wire
Earnings Scheduled For March 21, 2022
Companies Reporting Before The Bell • Marinus Pharmaceuticals (NASDAQ:MRNS) is likely to report quarterly loss at $0.76 per share on revenue of $3.37 million. •... 
Via Benzinga
How To Attend UroGen Pharma Q4 2021 Earnings Conference Call
UroGen Pharma (NASDAQ:URGN) will host a conference call at 10:00 AM ET on March 21, 2022, to discuss Q4 2021 earnings results. How to Attend UroGen Pharma (URGN) Conference Call... 
Via Benzinga
Earnings Outlook For UroGen Pharma
UroGen Pharma (NASDAQ:URGN) is set to give its latest quarterly earnings report on Monday, 2022-03-21. Here's what investors need to know before the announcement. Analysts... 
Via Benzinga
UroGen Pharma Q4 2021 Earnings Conference Call On March 21, 2022 At 10:00 AM ET
UroGen Pharma (NASDAQ:URGN) will host a conference call at 10:00 AM ET on March 21, 2022, to discuss Q4 2021 earnings results. How to Attend UroGen Pharma (URGN) Conference Call... 
Via Benzinga
Earnings Outlook For UroGen Pharma
UroGen Pharma (NASDAQ:URGN) is set to give its latest quarterly earnings report on Thursday, 2022-03-10. Here's what investors need to know before the announcement. Analysts... 
Via Benzinga
88 Biggest Movers From Yesterday
Gainers Hycroft Mining Holding Corporation (NASDAQ: HYMC) climbed 203.3% to settle at $1.00 on Tuesday. Hycroft recently reported preliminary FY21 operating results. Kala... 
Via Benzinga
UroGen Pharma to Participate in Panel Discussion at Cowen 42nd Annual Healthcare Conference
From UroGen Pharma Ltd.
Via Business Wire
Stocks That Hit 52-Week Lows On Tuesday
During Tuesday's trading, 505 companies set new 52-week lows. Noteworthy Highlights From Today's 52-Week Lows: The company with the largest market cap to... 
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
On Friday, 313 companies hit new 52-week lows. Things to Consider About Today's 52-Week Lows: The largest company in terms of market cap to set a new 52-week... 
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
On Thursday, 147 companies achieved new lows for the year. Significant Points From Today's 52-Week Lows: PayPal Holdings (NASDAQ:PYPL) was the biggest company... 
Via Benzinga
UroGen Announces Data that Shows In-Office Nephrostomy Tube Administration of Jelmyto® is Efficient for Doctors and Well Tolerated by Patients
From UroGen Pharma Ltd.
Via Business Wire
UroGen Announces Start of Pivotal Single-Arm Phase 3 Trial for UGN-102, an Investigational Non-Surgical Treatment for Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer
From UroGen Pharma Ltd.
Via Business Wire
UroGen Pharma to Present at Upcoming Conferences
From UroGen Pharma Ltd.
Via Business Wire
First Patient Dosed in UroGen Pharma’s Home Instillation Study of UGN-102 in Patients with Low-Grade Intermediate Risk Non-Muscle Invasive Bladder Cancer (LG IR-NMIBC)
From UroGen Pharma Ltd.
Via Business Wire
Stocks That Hit 52-Week Lows On Friday
During Friday's session, 445 companies made new 52-week lows. Noteable 52-Week Lows: Intuitive Surgical (NASDAQ:ISRG) is the largest company in terms of market cap to... 
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
On Thursday, 615 stocks hit new 52-week lows. Noteable 52-Week Lows: Sea (NYSE:SE) is the largest company in terms of market cap to set a new 52-week low this... 
Via Benzinga
UroGen Pharma Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
From UroGen Pharma Ltd.
Via Business Wire
70 Biggest Movers From Yesterday
Gainers Casper Sleep Inc. (NYSE: CSPR) shares jumped 88.5% to close at $6.69 on Monday after the company agreed to be acquired by Durational Capital Management. The... 
Via Benzinga
UroGen Pharma Reports Third Quarter 2021 Financial Results and Recent Corporate Developments
From UroGen Pharma Ltd.
Via Business Wire
The Week Ahead In Biotech (Nov. 14-Nov. 20): BioMarin FDA Decision, Tapering Earnings News Flow, Conference Presentations And More
Biotech stocks declined for the second straight week amid a broader market pullback, along with earnings news from small- and micro-cap companies and presentations at... 
Via Benzinga
Earnings Scheduled For November 15, 2021
Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is estimated to report earnings for its third quarter. • Tyson Foods (NYSE:TSN) is estimated to... 
Via Benzinga
< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today